Drugs / DHEA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01846442 | Jun 2007 → May 2008 | postmenopausal atrophic vaginitis | EndoCeutics Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DHEA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01846442 ↗ |
| Route | Other | “randomized to receive daily one of four DHEA concentrations intravaginally.” PMID 19436226 ↗ Sep 2009 |